Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 7
Submit an article Journal homepage
299
Views
10
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Impact of clinical factors on outcome of leukemia patients with TLS-ERG fusion gene

Jing PanDepartment of Hematology, Hebei Yanda Lu Daopei Hospital, Langfang, China;
,
Yang ZhangPathology & Laboratory Medicine Division, Hebei Yanda Lu Daopei Hospital, Langfang, China;
,
Yan-Li ZhaoDepartment of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, China
,
Jun-Fang YangDepartment of Hematology, Hebei Yanda Lu Daopei Hospital, Langfang, China;
,
Jian-Ping ZhangDepartment of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, China
,
Hong-Xing LiuPathology & Laboratory Medicine Division, Hebei Yanda Lu Daopei Hospital, Langfang, China;
,
Tong WuDepartment of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, ChinaCorrespondence[email protected]
&
Chun-Rong TongDepartment of Hematology, Hebei Yanda Lu Daopei Hospital, Langfang, China; Correspondence[email protected]
 show all
Pages 1655-1663 | Received 26 Jul 2016, Accepted 06 Nov 2016, Published online: 22 Nov 2016

References

  • Crozat A, Aman P, Mandahl N, et al. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature. 1993;363:640–644.
  • Rabbitts TH, Forster A, Larson R, et al. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet. 1993;4:175–180.
  • Mecucci C, Bosly A, Michaux JL, et al. Acute nonlymphoblastic leukemia with bone marrow eosinophilia and structural anomaly of chromosome 16. Cancer Genet Cytogenet. 1985;17:359–363.
  • Morgan R, Riske CB, Meloni A, et al. T(16;21)(p11.2;q22): a recurrent primary rearrangement in ANLL. Cancer Genet Cytogenet. 1991;53:83–90.
  • Nobbs MC, Chan-Lam D, Howell RT, et al. Acute non-lymphocytic leukemia with t(16;21). Cancer Genet Cytogenet. 1993;70:144–145.
  • Ferro MR, Cabello P, Garcia-Sagredo JM, et al. T(16;21) in a Ph positive CML. Cancer Genet Cytogenet. 1992;60:210–211.
  • Shing DC, McMullan DJ, Roberts P, et al. FUS/ERG gene fusions in Ewing's tumors. Cancer Res. 2003;63:4568–4576.
  • Oh SH, Park TS, Choi JR, et al. Two childhood cases of acute leukemia with t(16;21)(p11.2;q22): second case report of infantile acute lymphoblastic leukemia with unusual type of FUS-ERG chimeric transcript. Cancer Genet Cytogenet. 2010;200:180–183.
  • Jekarl DW, Kim M, Lim J, et al. CD56 antigen expression and hemophagocytosis of leukemic cells in acute myeloid leukemia with t(16;21)(p11;q22). Int J Hematol. 2010;92:306–313.
  • Ismael O, Shimada A, Elmahdi S, et al. RUNX1 mutation associated with clonal evolution in relapsed pediatric acute myeloid leukemia with t(16;21)(p11;q22). Int J Hematol. 2014;99:169–174.
  • Yan-Li Z, Tong W, Yue L, et al. Improved outcomes of haploidentical blood and marrow transplantation in hematologic malignancies: a single center study of 514 cases [Abstract]. Blood. 2015;126:3224.
  • Chang H, Brandwein J, Yi QL, et al. Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome. Leuk Res. 2004;28:1007–1011.
  • Goyal SD, Zhang MJ, Wang HL, et al. Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome. Bone Marrow Transplant. 2015;50:1057–1062.
  • Bohl S, von Harsdorf S, Mulaw M, et al. strong impact of extramedullary involvement in high-risk AML patients with active disease receiving the FLAMSA conditioning regimen for HSCT. Bone Marrow Transplant. 2016;51:994–996.
  • National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: acute lymphoblastic leukemia, version I. 2015[EB/OL]. [cited 2015 Nov 16]; Available from: https://www.nccn.org/store/login/login.aspx?ReturnURL= http://www.nccn.org/professionals/physician_gls/pdf/all.pdf.
  • National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: acute myeloid leukemia, version I. 2015[EB/OL]. [cited 2015 Nov 16]; Available from: https://www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/aml.pdf.
  • Xiao-Tang K, Kohmei I, Hitoshi I, et al. Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16; 21)(p11; q22) and identification of a novel transcript. Blood. 1997;90:1192–1199.
  • Kanazawa T, Ogawa C, Taketani T, et al. TLS/FUS-ERG fusion gene in acute lymphoblastic leukemia with t(16;21)(p11;q22) and monitoring of minimal residual disease. Leuk Lymphoma. 2005;46:1833–1835.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.